Likewise, pharmacological inhibition of SERT activity by antidepressants such as selective serotonin reuptake inhibitors (SSRI) is reported to be associated with an increased risk of type-2 diabetes (24). This evidence concerns the gene SLC6A4 and type 2 diabetes mellitus.